Comments of DPR's RCD for Paclobutrazol

OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Paclobutrazol. These comments and our recommendations, as well as suggested clarifications, additions and corrections, are contained in the attachment.

Chemical Reference

• Paclobutrazol